Lava Medtech Acquisition Stock Current Liabilities
| LVACUDelisted Stock | USD 10.40 0.00 0.00% |
Lava Medtech Acquisition fundamentals help investors to digest information that contributes to Lava Medtech's financial success or failures. It also enables traders to predict the movement of Lava Stock. The fundamental analysis module provides a way to measure Lava Medtech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Lava Medtech stock.
Lava |
Lava Medtech Acquisition Company Current Liabilities Analysis
Lava Medtech's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
CompetitionIn accordance with the recently published financial statements, Lava Medtech Acquisition has a Current Liabilities of 0.0. This is 100.0% lower than that of the Financial Services sector and about the same as Shell Companies (which currently averages 0.0) industry. The current liabilities for all United States stocks is 100.0% higher than that of the company.
Lava Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Lava Medtech's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Lava Medtech could also be used in its relative valuation, which is a method of valuing Lava Medtech by comparing valuation metrics of similar companies.Lava Medtech is currently under evaluation in current liabilities category among its peers.
Lava Fundamentals
| Return On Asset | -0.0081 | |||
| Shares Owned By Institutions | 10.18 % | |||
| Number Of Shares Shorted | 105 | |||
| EBITDA | (6.22 M) | |||
| Net Income | 4.5 M | |||
| Cash And Equivalents | 1.15 M | |||
| Cash Per Share | 0.08 X | |||
| Total Debt | 92.81 K | |||
| Debt To Equity | 4.92 % | |||
| Current Ratio | 18.29 X | |||
| Book Value Per Share | (0.21) X | |||
| Cash Flow From Operations | (658.82 K) | |||
| Short Ratio | 1.88 X | |||
| Total Asset | 120.67 M | |||
| Retained Earnings | (3.01 M) | |||
| Working Capital | (3.39 M) | |||
| Z Score | -0.24 | |||
| Net Asset | 120.67 M |
About Lava Medtech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Lava Medtech Acquisition's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lava Medtech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lava Medtech Acquisition based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Consideration for investing in Lava Stock
If you are still planning to invest in Lava Medtech Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Lava Medtech's history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |